Nortriptyline Hydrochloride Capsule
NDC Package 70710-1155-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Nortriptyline Hydrochloride capsules are indicated for the relief of symptoms of depression. This formulation utilizes a capsule delivery system. Marketed by Zydus Pharmaceuticals (usa) Inc., this product is identified by NDC 70710-1155 and is authorized under FDA application ANDA213441.

Identification & Billing

NDC Package Code
70710-1155-1
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
70710-1155
11-Digit Billing Format
70710115501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nortriptyline Hydrochloride
Non-Proprietary Name
Nortriptyline Hydrochloride
Substance Name
Nortriptyline Hydrochloride
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
NORTRIPTYLINE HYDROCHLORIDE 50 mg/1
Pharmacologic Class
Tricyclic Antidepressant - [EPC] (Established Pharmacologic Class)
Usage Information
Nortriptyline hydrochloride capsules are indicated for the relief of symptoms of depression. Endogenous depressions are more likely to be alleviated than are other depressive states.

Regulatory & Marketing

Labeler Name
Zydus Pharmaceuticals (usa) Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA213441
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-10-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70710-1155). Click a package code to view its specific billing and regulatory data.

70710-1155-3
30 CAPSULE in 1 BOTTLE
70710-1155-5
500 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70710-1155-1 identifies a specific commercial package of 100 capsule in 1 bottle of Nortriptyline Hydrochloride, a human prescription drug labeled by Zydus Pharmaceuticals (usa) Inc.. This capsule is formulated for oral use and contains nortriptyline hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals (usa) Inc. on February 10, 2022. The current certification is valid through December 31, 2026.

How is this Zydus Pharmaceuticals (usa) Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710115501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70710-1155-1
11-Digit CMS (5-4-2)
70710-1155-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.